Tag: dazukibart

Dazukibart is effective in reducing disease activity in adults with refractory dermatomyositis

byNeel Mistryand1 others

February 12, 2025

1. CDASI-A score at 12 weeks was significantly lower in dazukibart 600 mg versus placebo, suggesting reduced morbidity. 2. Treatment-related ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy
Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization
Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

No Result

View All Result